AzTrials
AzTrials

StrokeNCT06450054

Effects of Aerobic Training in Diabetic vs Non-Diabetic Post-Stroke Patients

A study testing Aerobic Exercise in diabetic post-stroke patients and Aerobic Exercise in Non diabetic post-stroke patients in people with Stroke, run by Superior University at 1 site in Pakistan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study aims to investigate the effects of aerobic training in post-stroke patients, both diabetic and non-diabetic, in terms of their metabolic response to exercise and psychosocial well-being. Read more about this study

Who is it for?
Ages 18 to 74 years
Conditions the study is for
Stroke
What is being tested?
Aerobic Exercise in diabetic post-stroke patients and Aerobic Exercise in Non diabetic post-stroke patients
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
18 participants
Where
1 sitePakistan
Study dates
1 Nov 2023to 29 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 74 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male and female post-stroke patients will be inactive or insufficiently active.
  • The Patient's age ranged from 18 to 74. They will have a balanced sitting position or can ambulate.
  • The stroke will not last less than six months and not more than two years.
  • Exercises will be performed at a vigorous intensity greater than 60% of the individual's maximum cardiorespiratory capacity.
  • Patients with adequate cognitive abilities (Mini-Mental Scale >24) to understand and obey instructions

Who cannot join

  • Unconscious patients or communication problems that could prevent them from completing the tests used in the study.
  • Those with bilateral or previous hemiplegia and sensory aphasia
  • Comorbid neurological diseases (multiple sclerosis, Parkinson's disease, spinal cord injury, traumatic brain injury, brain tumour, etc.
  • Those with any contraindications for the maximum exercise test
  • Cardiovascular or pulmonary conditions (unsettled angina, current myocardial infarction during the last three months, congestive heart failure, severe heart valve dysfunction)
  • Musculoskeletal problems such as extreme arthritis and fracture

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • IMC Physical Therapy Hospital (Neuro-Rehab Department) DHA

    Lahore

Other trials in Pakistan

About this study

The study aims to investigate the effects of aerobic training in post-stroke patients, both diabetic and non-diabetic, in terms of their metabolic response to exercise and psychosocial well-being. It is crucial to understand the metabolic changes that occur due to stroke and diabetes, including glucose and lipid profiles.

Read the detailed description

The study will explore how aerobic training can influence insulin sensitivity and lipid metabolism differently in diabetic and non-diabetic patients, which may affect overall recovery outcomes. It is also essential to assess psychosocial well-being, including depression and satisfaction with life. Aerobic exercise has been shown to improve mood and enhance overall quality of life in post-stroke patients. By assessing these variables comprehensively, tailored rehabilitation strategies can be developed to optimise metabolic and psychosocial outcomes in diabetic and non-diabetic post-stroke populations, ultimately improving overall well-being and quality of life.

Conditions
Stroke
Being tested
Aerobic Exercise in diabetic post-stroke patients, Aerobic Exercise in Non diabetic post-stroke patients
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aerobic Exercise in diabetic post-stroke patientsDiagnostic test

    The experimental group's members will use the treadmill for a five-minute warm-up and cool-down. Over 12 weeks, they will attend three 40-minute weekly sessions in groups of two to four. They will then perform aerobic exercise for thirty minutes at a heart rate reserve of 60% to 80%. Those with a low exercise tolerance will first be given small workouts lasting at least ten minutes, interspersed with rest periods until they can perform 30 minutes of exercise. They will progress to longer, continuous workouts punctuated by shorter rest periods as their tolerance to exercise grows. The degree of treadmill training intensity will be adjusted step-by-step according to each person's tolerance, heart rate, blood pressure responses, and perceived effort rate. If they exercise beyond their cardiovascular conditioning zone, participants will be instructed to raise their treadmill speed until they achieve it

  • Aerobic Exercise in Non diabetic post-stroke patientsOther

    Group B will be managed aerobic exercise in non-diabetic post-stroke patients. Participants in the control group will walk outside comfortably while maintaining a heart rate reserve of less than 40%. They will be instructed to reduce their pace until their training zone reaches ≤40% if their heart rate reserve exceeds 40%. If the efficacy is demonstrated, participants in the control group will receive the experimental intervention

Study groups in NCT06450054
Study groupRoleWhat they receive
Aerobic Exercise in diabetic post-stroke patientsActive comparatorNot described
Receives: Diagnostic Test: Aerobic Exercise in diabetic post-stroke patients
Aerobic Exercise in Non diabetic post-stroke patientsSham comparatorNot described
Receives: Other: Aerobic Exercise in Non diabetic post-stroke patients

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Beck Depression Inventory (BDI)

    scores range from 0 to 63 or 84, indicating the severity of depressive symptoms. Higher scores signify more severe depression: 0-9 (minimal), 10-18 (mild), 19-29 (moderate), and 30-63 or 30-84 (severe).

    Measured: 12 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2024
  2. Study start1 Nov 2023
  3. Primary completion1 Apr 2024
  4. Study completion29 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06450054
Sponsor's protocol ID
MSRSW/Batch-Fall22/714
Status last verified
Jun 2024
First submitted
25 May 2024
Last updated
10 Jun 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Aerobic Exercise in diabetic post-stroke patients and Aerobic Exercise in Non diabetic post-stroke patients in people with Stroke, run by Superior University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Beck Depression Inventory (BDI) (time frame: 12 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in